Innovating Works
SC1-PM-13-2016
SC1-PM-13-2016: PPI for deployment and scaling up of ICT solutions for active and healthy ageing
Specific Challenge:The fast growing ageing population in Europe is bringing new demand-side pressures on public health and care providers. These pressures undermine the long-term sustainability of existing models of delivering care services to the ageing population.
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 16-02-2016.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos: Objetivo del proyecto:

Specific Challenge:The fast growing ageing population in Europe is bringing new demand-side pressures on public health and care providers. These pressures undermine the long-term sustainability of existing models of delivering care services to the ageing population.

The challenge is to scale up innovative solutions, which have been tested and have demonstrated success in smaller scale settings and that have not yet been deployed on a large scale, by contributing to collaborative efforts in public purchasing of innovative ICT-based solutions for active and healthy ageing. These include inter alia integrated care and active ageing solutions, independent living solutions and telecare, support for self-care and person-centred care. Moreover, take-up of these ICT-based solutions by both public care providers as well as people in need for care is a crucial factor in successfully alleviating the demand-side pressures on public health and care provision.


Scope:This topic will contribute to the Scaling-Up Strategy[1] of the European Innovation Partnership on Active and Healthy Ageing and to boosting the Silver Economy and Digital Single Market in Europe. The... ver más

Specific Challenge:The fast growing ageing population in Europe is bringing new demand-side pressures on public health and care providers. These pressures undermine the long-term sustainability of existing models of delivering care services to the ageing population.

The challenge is to scale up innovative solutions, which have been tested and have demonstrated success in smaller scale settings and that have not yet been deployed on a large scale, by contributing to collaborative efforts in public purchasing of innovative ICT-based solutions for active and healthy ageing. These include inter alia integrated care and active ageing solutions, independent living solutions and telecare, support for self-care and person-centred care. Moreover, take-up of these ICT-based solutions by both public care providers as well as people in need for care is a crucial factor in successfully alleviating the demand-side pressures on public health and care provision.


Scope:This topic will contribute to the Scaling-Up Strategy[1] of the European Innovation Partnership on Active and Healthy Ageing and to boosting the Silver Economy and Digital Single Market in Europe. The actions supported will target deployment of active and healthy ageing solutions at large scale across different regions in Europe.

In line with the priority actions of the Scaling-up Strategy, the scope of the PPI pilot(s) is to specify, purchase and deploy ICT based solutions for active and healthy ageing which can deliver sustainable, new or improved services in which public procurement approaches for innovative solutions are successfully applied.

Proposals should:

Be driven by clearly identified procurement needs of the participating organisations and building on a complete understanding of the needs of the ageing population, as well as the needs of the relevant health and care providers; Support sustainable deployment of new or improved services by providers involved in the procurement of solutions for active and healthy ageing; Contribute to the creation of scalable markets across Europe in innovative solutions for active and healthy ageing; Specify measures that will ensure the sustainability of solutions beyond the lifespan of the proposed project; Engage public and/or private procurers from each country participating (at national, regional or local level) that have responsibilities and budget control in the relevant area of care or supply of services; Be based on a complete set of common specifications for end to end services; Demonstrate that the implementation phase will reach "large scale" (i.e. sufficient scale to achieve statistical significance) through region-wide deployment across multiple regions of Europe; Contribute to the use of interoperable solutions based on open platforms and take into account existing best practices and standardisation initiatives; Provide robust safeguards to ensure compliance with ethical standards and privacy protections and take account of the gender dimension; Contribute good practices to be made available for replication across other regions (e.g. "detailed plans" for larger scale sustainable uptake of innovative solutions for active and healthy ageing, reference material and guidelines, manuals and education materials). The European Commission considers that proposals requesting a contribution from the EU of between EUR 2 and 5 million would allow this specific challenge to be addressed appropriately through PPI. This does not preclude submission and selection of proposals requesting other amounts.


Expected Impact: Growing awareness and successful use of public procurement to boost ICT innovation applied to active and healthy ageing, ultimately benefiting the growing ageing population across Europe; Contribution with data and experiences to regulatory and legislative process development addressing potential barriers to procurement of innovative solutions for active and healthy ageing; Contribution of an open and comprehensive socio-economic evidence base for ICT investments in the field that can support the development of sustainable business models (e.g. cost-benefit analysis, increased efficiency of health and care systems, impact assessments, return on investments, quality of life improvements for users, ethics, safety gain and user satisfaction); Support initiatives on interoperability and standardisation that can contribute to defragmentation of the market for ICT based active and healthy ageing solutions; Creation of economic boundary conditions that can support long-term sustainability of health and care systems and emergence of new business models to develop ICT innovation for active and healthy ageing in Europe; Support forward-looking, concerted public-sector investment strategies that benefit from joint approaches across different regions; Create new opportunities for market uptake and economies of scale for the supply side for ICT based solutions and services for active and healthy ageing in a Digital Single Market for Europe. Contribute to inform policy measures that foster the take-up of ICT solutions for active and healthy ageing.
Cross-cutting Priorities:Innovation ProcurementGender


[1]European Scaling-up Strategy in Active and Healthy Ageing: https://ec.europa.eu/research/innovation-union/pdf/active-healthy-ageing/scaling_up_strategy.pdf

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Specific Challenge:The fast growing ageing population in Europe is bringing new demand-side pressures on public health and care providers. These pressures undermine the long-term sustainability of existing models of delivering care services to the ageing population. Specific Challenge:The fast growing ageing population in Europe is bringing new demand-side pressures on public health and care providers. These pressures undermine the long-term sustainability of existing models of delivering care services to the ageing population.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Amortizaciones.
Activos.
Otros Gastos.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Please read carefully all provisions below before the preparation of your application.
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Public Pro...
Please read carefully all provisions below before the preparation of your application.
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Public Procurement of Innovative Solutions (PPI):
Specific provisions and funding rates
The funding rate for PPI actions is limited to 35% of the total eligible costs to leverage co-financing from the procurers in this specific case.
Standard proposal template
Standard evaluation form
Annotated Grant Agreement
Specific requirements for innovation procurement supported by Horizon 2020 grants (PCP, PP)
 
Additional provisions:
Horizon 2020 budget flexibility
Classified information
 
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
 
Additional documents:
H2020 Work Programme 2016-17: Introduction
H2020 Work Programme 2016-17: Health, demographic change and wellbeing
H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
H2020 Work Programme 2016-17: General Annexes
Legal basis: Horizon 2020 - Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
 
Additional Information on this Topic:
FAQ
 
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
H2020-SC1-2016-2017 PPI for deployment and scaling up of ICT solutions for active and healthy ageing Specific Challenge:The fast growing ageing population in Europe is bringing new demand-side pressures on public health and care providers. T...
Sin info.
SC1-PM-11-2016-2017 Clinical research on regenerative medicine
en consorcio:
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-20-2017 Methods research for improved health economic evaluation
en consorcio: Specific Challenge:Health systems need to be resilient. They must be able to adapt effectively to changing environments, and tackle signific...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-03-2017 Diagnostic characterisation of rare diseases
en consorcio: Specific Challenge:Rare diseases are diseases which affect not more than 5 per 10 000 persons in the European Union. It is estimated that ra...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products
en consorcio: Specific Challenge:In biomedical, pharmaceutical and toxicology research, the safety and efficacy of biomedical products is ultimately teste...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-19-2017 PPI for uptake of standards for the exchange of digitalised healthcare records
en consorcio: Specific Challenge:The use of interoperability standards is essential to the wider deployment of an EU eHealth single market. Despite previo...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de